WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H572159
CAS#: 1817735-32-2
Description: t-Boc-N-amido-PEG3-sulfonic acid is a biochemical. PEG Linkers may be useful in the development of antibody drug conjugates.
Hodoodo Cat#: H572159
Name: t-Boc-N-amido-PEG3-sulfonic acid
CAS#: 1817735-32-2
Chemical Formula: C13H27NO8S
Exact Mass: 357.15
Molecular Weight: 357.420
Elemental Analysis: C, 43.69; H, 7.61; N, 3.92; O, 35.81; S, 8.97
Synonym: t-Boc-N-amido-PEG3-sulfonic acid
IUPAC/Chemical Name: 2,2-dimethyl-4-oxo-3,8,11,14-tetraoxa-5-azahexadecane-16-sulfonic acid
InChi Key: OVHIYMDHNOIKJZ-UHFFFAOYSA-N
InChi Code: InChI=1S/C13H27NO8S/c1-13(2,3)22-12(15)14-4-5-19-6-7-20-8-9-21-10-11-23(16,17)18/h4-11H2,1-3H3,(H,14,15)(H,16,17,18)
SMILES Code: O=C(OC(C)(C)C)NCCOCCOCCOCCS(O)(=O)=O
Appearance: Solid powder
Purity: >97% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >3 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.03.00
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 357.42 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1: Zhang P, Huang Y, Liu H, Marquez RT, Lu J, Zhao W, Zhang X, Gao X, Li J, Venkataramanan R, Xu L, Li S. A PEG-Fmoc conjugate as a nanocarrier for paclitaxel. Biomaterials. 2014 Aug;35(25):7146-56. doi: 10.1016/j.biomaterials.2014.04.108. Epub 2014 May 22. PubMed PMID: 24856103; PubMed Central PMCID: PMC4102141.
2: Salmaso S, Bersani S, Scomparin A, Mastrotto F, Scherpfer R, Tonon G, Caliceti P. Tailored PEG for rh-G-CSF analogue site-specific conjugation. Bioconjug Chem. 2009 Jun;20(6):1179-85. doi: 10.1021/bc9000432. PubMed PMID: 19469471.